June 1, 2023 12:30 AM
Latest:
  • News Corp vs. the Transition To Influencer Advertising
  • Profit Padding: Unveiling the Hidden Driver of Persistent Inflation
  • Elon Musk Boosts Potentially Harmful AOC Parody Account
  • Twitter’s Now Worth Just A Third of What Elon Musk Paid for It
  • Elizabeth Holmes Begins Serving 11-Year Sentence At Texas Prison
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Latest
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Ketamine

Latest News Psychedelics 

PharmaTher Files With FDA For Orphan Drug Designation In Use Of Ketamine For ALS

May 25, 2021 9:00 AMMay 25, 2021 9:00 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as

Share
Tweet
Share
Read more
Latest News Psychedelics 

PharmaTher Receives FDA Approval For Ketamine Trial For Parkinson’s

May 17, 2021 9:15 AMMay 17, 2021 9:15 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Holdings (CSE: PHRM) has seen the US FDA approve the firms application for an investigational new drug. The approval

Share
Tweet
Share
Read more
Latest News Psychedelics 

PharmaTher Acquires Exclusive Rights To Patented Ketamine Formulation

January 19, 2021 9:24 AMJanuary 19, 2021 9:24 AM Jay Lutz 0 Comments Ketamine, Pharmather

PharmaTher Inc (CSE: PHRM) has entered into an exclusive worldwide license agreement for the development and commercialization of a patented

Share
Tweet
Share
Read more
Latest Psychedelics Video Series 

Artificial Intelligence Meets Psychedelics – The Daily Dive feat Fabio Chianelli

November 24, 2020 1:00 PMNovember 24, 2020 12:19 PM Jay Lutz 0 Comments Fabio Chianelli, Ketamine, Pharmather

Today on the Daily Dive, Fabio Chianelli, CEO of PharmaTher Inc (CSE: PHRM) sits down with our host Cassandra Leah

Share
Tweet
Share
Read more
Latest Psychedelics 

Harvest Moon: Reducing Suicidal Ideation With Ketamine Infusions

May 26, 2020 3:00 PMJune 22, 2022 2:03 PM Harvest Moon Research 1 Comment Champignon Brands, Harvest Moon Research, Johnson & Johnson, Ketamine

Suicidal ideation is an emergent condition that demands immediate attention. It has been shown that the time between decision and

Share
Tweet
Share
Read more

Latest

  • News Corp vs. the Transition To Influencer Advertising

  • Profit Padding: Unveiling the Hidden Driver of Persistent Inflation

  • Elon Musk Boosts Potentially Harmful AOC Parody Account

  • Twitter’s Now Worth Just A Third of What Elon Musk Paid for It

  • Elizabeth Holmes Begins Serving 11-Year Sentence At Texas Prison

  • Canadian Population To Hit 100 Million, Thanks To Immigrants

  • SEC Slaps $3 Million Penalty on Former Wells Fargo Executive for Alleged Misleading Statements

  • National Bank Continues Lower Profit, Higher Dividend Trend

Video

The Quiznos Story: From Huge Success To Huge Bust
Food Full Analysis Latest Video Series 

The Quiznos Story: From Huge Success To Huge Bust

May 30, 2023 1:30 PM Jay Lutz 0

Remember Spongemonkeys? The bizarre, screeching rodents known for singing the praises of Quiznos subs. Today, we’re diving into the story

Trending

  • S&P Global Withdraws Canopy Growth's Credit Ratings At Company's Request
  • Shopify CEO Collects $20 Million In Compensation Despite Job Cuts
  • Eguana Sees Q1 2023 Revenue Climb On Expansion Strategy
  • Ottawa Resets Assessment Process For Ring Of Fire
  • Canadian Population To Hit 100 Million, Thanks To Immigrants

News

Eguana Sees Q1 2023 Revenue Climb On Expansion Strategy
Latest News Technology 

Eguana Sees Q1 2023 Revenue Climb On Expansion Strategy

May 31, 2023 9:32 AM ER Velasco 0

Eguana Technologies (TSXV: EGT) reported its Q1 2023 financials, topbilled by a quarterly revenue of $5.9 million. While its a drop from the record-breaking quarter of Q4 2022 which posted $10.3 million in revenue, the first quarter’s topline figure is a surge of nearly 2,000% from revenue of approximately $285,000 in the year-ago period.

Trillion Energy Posts Q1 Revenues Of US$6.1 Million
Energy Latest News 

Trillion Energy Posts Q1 Revenues Of US$6.1 Million

May 31, 2023 8:32 AM Jay Lutz 0
Power Nickel Intersects 1.01% Nickel Over 14 Metres
Latest News Resources 

Power Nickel Intersects 1.01% Nickel Over 14 Metres

May 30, 2023 8:20 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.